Radio and PodcastLive Radio & PodcastsLoading episode
Fetching episode details...
Radio and PodcastLive Radio & PodcastsRadio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
"Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab).
What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer is an episode from GRACEcast by Howard (Jack) West, MD. "Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined h...
This episode belongs to GRACEcast.
Use the player on this page to stream the episode online.
Published Jul 8, 2014, 03:52 long, audio available.
Continue listening to more episodes from GRACEcast.
Jul 29, 2014 - 01:55
Jul 24, 2014 - 02:03
Jul 20, 2014 - 04:40
Jul 15, 2014 - 03:15